Summary: A combination of approaches -gene mapping, biomarker analysis, and studies of signal transduction -has helped to clarify the mechanisms of age-related change in mouse immune status and the implications of immune aging for late-life disease. Mapping studies have documented multiple quantitative trait loci (QTL) that influence the levels of age-sensitive T-cell subsets. Some of these QTL have effects that are demonstrable in young-adult mice (8 months of age) and others demonstrable only in middle-aged mice (18 months). Biomarker studies show that T-cell subset levels measured at 8 or 18 months are significant predictors of lifespan for mice dying of lymphoma, fibrosarcoma, mammary adenocarcinoma, or all causes combined. Mice whose immune systems resemble that of young animals, i.e. with low levels of CD4 þ and CD8 þ memory T cells and relatively high levels of CD4 þ T cells, tend to outlive their siblings with the opposite subset pattern. Biochemical analyses show that T cells from aged mice show defects in the activation process within a few minutes of encountering a stimulus and that the defects precede the recognition by the T-cell receptor of agonist peptides on the antigen-presenting cell. Defective assembly of cytoskeletal fibers and hyperglycosylation of T-cell surface glycoproteins contribute to the immunodeficiency state, and indeed treatment with a sialylglycoprotein endopeptidase can restore full function to CD4 þ T cells from aged donors in vitro.
Introduction
The immune system is the gerontologist's playground. Immune systems fail with age in clinically significant ways, can be dissected in vitro and re-assembled in vivo, and are the obsession of legions of professional immunologists who, because they do not care that much about aging, are often willing to share cell lines, mouse stocks, antibodies, and ideas. This article presents illustrations of ways in which the momentum and accomplishments of the immunological community can be brought to bear on three problems in aging research: genetic control of late-life changes, pathobiology of aging and cancer, and the cell biology of immune failure.
Genetic dissection of T-cell subset changes in aging mice
Our genetic analyses employ mice of a stock called UM-HET3, created by a four-way cross in which CB6F1 females are mated to C3D2F1 males. The individual animals are the genetic equivalent of full siblings; no two pups are the same. Each individual shares a random 50% of its genetic endowment with every other animal in the population, receiving approximately 25% of its alleles from each of the four grandparental strains, BALB/cJ, C57BL/6 J, C3H/HeJ, and DBA/2 J. DNA from each mouse is genotyped at 100-300 polymorphic alleles to acquire a moderate resolution picture of which chromosomal segments it has inherited from each of the four grandparents. Each mouse is then evaluated for phenotypic traits of interest, for example, levels of age-sensitive T-cell subsets, and a permutation-adjusted regression analysis then looks for loci at which one of the alleles has a greater than random level of association with a trait of interest.
We have used these methods (1, 2) to document genetic controls of seven T-cell subsets: CD4 þ and CD8 þ cells, CD4 þ and CD8 þ memory cells (using CD44 level as an index of memory cell differentiation; abbreviated CD4M and CD8M), CD4 þ naïve cells (using CD45RB as index), and subpopulations of CD4 þ and CD8 þ cells that express P-glycoprotein (referred to as CD4P and CD8P). These latter two subsets are of special interest, because their proportions increase dramatically with age (3), even in naïve T cells in T-cell receptor (TCR) transgenic (Tg) mice in which conversion of naïve to memory cells is greatly slowed (4) , and because CD4P cells are anergic in tests of proliferation, cytokine production, and calcium signal generation (5) (6) (7) . Catalogs of alleles that modulate each of these T-cell subsets (1, 2) are now available, and they will be of use in studies of genetic controls of late-life immune function and susceptibility to neoplastic and autoimmune illnesses and immunodeficiency states. Here, we use them to illustrate two broader themes: (i) stage-specific effects on age-sensitive traits and (ii) use of composite indices of agedependent T-cell patterns. The top panels of Fig. 1 show examples of loci that influence age-sensitive T-cell subsets, but they do so through actions that affect mice in the first third of the lifespan and remain consistent at least through 18 months of age. The upper left panel, for example, shows that mice that inherit the B6 allele linked to the chromosome 12 marker D12Mit105 tend to have higher levels of CD8M cells. This difference is apparent in mice evaluated at 8 months of age, and it is still present, and to the same degree, when the mice are tested at 18 months of age. The upper right panel shows another genetic polymorphism between BALB/c and B6 mice, this one linked to the D12Mit34 marker, which modulates CD4M levels at both ages tested. In this case, it is the BALB/c allele that is associated with the higher memory cell levels. In both these cases and in others tabulated in the references cited, the levels of the T-cell subsets differ in young adult mice and then shift in an alleleindependent way as the mice get older. In contrast, the bottom two panels of Fig. 1 show examples of loci where polymorphisms have no influence on subset levels in young adults (i.e. 8-month-old mice), but instead modify the rate at which the subsets change in the ensuing 10-month period. The left panel shows the effect of a chromosome 9 quantitative trait locus (QTL) on CD4P cell levels, in which the polymorphism is inherited from the (C3H Â DBA/2) F1 parent, and the right panel shows a maternal locus that influences the rate of change of CD8 þ cells in aging mice. Similar analyses have been used to map polymorphisms that regulate age-sensitive B-cell subsets in the same population of UM-HET3 mice (Labrie et al., manuscript submitted), T-cell proliferation responses (Miller et al., unpublished observations) , and a wide range of other phenotypes including hormone levels (8), cataracts (9), bone fragility (10), and lifespan (11, 12) .
T-cell subset levels as predictors of lifespan and cancer risk
The experimental protocol used to monitor T-cell subset levels in aging UM-HET3 mice does not require that the mice be killed, and thus it permits a test of the idea that those mice whose immune systems show the most advanced signs of aging are indeed likely to die at earlier ages than those mice with younger looking T-cell subset patterns. There are two underlying models, not mutually exclusive. The 'biomarker' model imagines that individual mice age at different rates, so that mice with faster rates of aging will show more rapid changes in T-cell subset patterns and also more rapid acquisition of lethal diseases, as well as rapid accumulation of other signs and symptoms of aging. The 'immune protection' model imagines that the immune systems of young mice confer protection against a wide range of late-life diseases and that those mice that retain youthful immune systems into old age are thereby protected against ill health. Initial evidence from a group of 173 mice showed that the proportion of CD4M cells in 18-month-old mice was a significant (P < 0.003) predictor of longevity in the UM-HET3 population (13) ; several other subsets showed suggestive associations that did not reach statistical significance (0.05 < P < 0.1) in this preliminary analysis. Consistent with the working hypothesis, mice with the highest levels of CD4M cells, i.e. mice whose immune system resembled that of older animals, tended to die at relatively early ages. A second report extended this analysis to a total of 559 mice (14) . In this larger group, five age-sensitive T-cell subsets among the seven studied were each found to be a significant predictor of lifespan when measured in blood at 18 months of age. In each case, the sign of the regression coefficient was consistent with the hypothesis that mice whose immune system resembled that of younger animals would tend to have longer lifespans. A cluster analysis method showed that when 18-month-old mice were divided into two groups based solely on similarity of T-cell subset patterns, one of the clusters resembled young mice (with relatively low levels of CD4M, CD8M, and CD4P cells and relatively high levels of CD4 and CD4 naïve cells), and that mice in this cluster were long-lived compared to the remainder of the population. The ability of the cluster approach to predict lifespan on the basis of T-cell subset patterns was equally apparent in virgin male mice, virgin females, and females that had given birth to multiple litters as young adults, and can thus be considered to be replicated in these three nonoverlapping groups.
A statistical approach based on principal components analysis was then applied to this data set in an attempt to develop an overall index of age-sensitive T-cell subset pattern changes that might be more informative than looking at each T-cell subset separately (15) . The algorithm forms a composite index as a weighted average of the values of each of the seven measured T-cell subsets, with weights chosen so as to maximize the amount of variation explained by the calculated index among the mice in the population. The calculated 'immune subset factor' was correlated strongly with the age-sensitive subsets, and indeed mice with high values of the calculated factor were those with relatively high CD8, CD4M, CD8M, and CD4P levels, and relatively low CD4 and CD4 naïve populations; in other words, mice with high-factor scores looked older in immunological terms. We then tested the prediction that mice with high levels of this factor would die young. Fig. 2 shows the relationship of principal component scores (termed 'F1_18' to indicate that it is calculated from data obtained at 18 months of age) to age at death in groups of mice that died of each of the three most common lethal illnesses, lymphoma (left), mammary adenocarcinoma (middle), and fibrosarcoma (right). Mice with young looking immune systems (low levels of the factor score) were likely to survive longer in each of the three diagnostic groups, as well as in the group of mice that died of some other cause (data not shown). The association between factor score and mortality risk was statistically significant for all four population subgroups, and reached P < 0.0001 for the mouse population as a whole. Thus these data suggest that mice whose changes in age-related T-cell subset pattern are either delayed or decelerated tend to be healthier in old age and survive longer. The association does not apply merely to a single cause of death, as would be Fig. 1 . Illustrations of quantitative trait loci (QTL) that modulate T-cell subset levels in UM-HET3 mouse populations. Four QTL are shown, two (top rows) whose influence on subset levels is apparent in 8-month-old mice and is maintained at least through 18 months, and two others (bottom row) whose effects are not apparent until 18 months of age. Each symbol shows mean level of the indicated subset (with standard error) in the population of mice bearing the indicated allele (example: BALB/c or B6 alleles for the D12Mit105 locus shown in the upper right panel). Each of these effects reaches statistical significance using experiment-wise criteria as explained previously (1, 2).
expected if, for example, preneoplastic changes in T-cell developmental pathways led both to lymphoma and to subset shifts. We favor the idea that mice with relatively rapid immune aging will also show rapid aging in other non-hematopoietic systems, and there is some support for this notion from evidence that aged mice with advanced subset shifts also have relatively weak muscles (16) . We cannot yet rule out, however, the immune protection hypothesis that rapid immune aging predisposes to multiple forms of late-life neoplastic disease.
A similar composite index of age-sensitive T-cell subsets was also found, in the same study (15) , to be able to predict remaining longevity when measured in mice as young as 8 months of age. These data are consistent with the hypothesis that age-dependent changes in T-cell subsets may be initiated, at least in some mice, at ages less than 8 months of age.
A more recent study (17) evaluated T-cell subsets as predictors of longevity in an independent replicate population of 539 UM-HET3 mice. Three of the tested subsets (CD4, CD8, and CD8M) were found to be significant predictors of lifespan when tested at 18 months of age, and CD8M cells were predictive as early as 8 months of age. A suggestive relationship was also noted for the CD4M subset (P < 0.07). Composite indices calculated by the principal component method were again found to be significant predictors of lifespan, whether evaluated at 8 or 18 months of age. Thus the main findings of the earlier studies (except for results on the CD4P subset, which were not replicated in the most recent population) seem to be fairly robust, at least for the genetically heterogeneous UM-HET3 population.
We have unpublished evidence that CD4M cells are significant predictors of life expectancy in female mice of two wild-derived mouse stocks (18) , one derived from mice trapped in Idaho (Id) and the other derived from mice trapped on the Pacific island of Majuro (Ma). Fig. 3 shows the relationship between CD4M levels, measured at 18 months of age, and age at death in these two stocks. A Cox regression analysis showed that the risk ratios were respectively 1.58 and 1.61 for all-cause mortality, both significant at P < 0.03. Similar results were seen in segregating populations of F2-hybrid mice created by crosses of Id or Ma to mice of the C57BL/6 J inbred stock. The risk ratios were 1.42 (P ¼ 0.07) for the (Id Â B6) F2 population and 1.79 (P ¼ 0.02) for the (Ma Â B6) F2 population. In each case, high levels of CD4M cells were associated with an increased mortality risk as in the UM-HET3 studies. We conclude from this finding that the association between high levels of CD4M cells and increased mortality risk is replicable in multiple mouse populations with different genetic backgrounds, including hybrids between wild-derived and laboratory-derived stocks.
Mapping the genes for age-sensitive immune subset patterns
Composite indices of T-cell subset patterns, by combining information from multiple, correlated T-cell subset measurements in each animal, could provide a more informative index of agerelated change than would be provided by any one subset tested by itself. Indeed, the data in Fig. 2 show that principal component factors developed in this way are able to predict lifespan, even in the relatively small groups of mice that share a specific cause of death. For this reason, we tested the idea that the composite scores themselves might be under the control of one or more polymorphic genetic loci, using the same methods that we had previously used to map QTL that moderated levels of specific T-cell subsets in young and old mice. In a population of >500 UM-HET3 mice, we found evidence for alleles at two loci, D4Mit55 and D13Mit21, each of which had a significant association with immune subset pattern as expressed in the principal component factor score (2) . Interestingly, neither of these loci had reached experiment-wise significance in the QTL screen that evaluated single subsets, consistent with the idea that the factor score, representing a combination of age-sensitive Tcell subsets, might itself be regulated by polymorphisms whose effects on individual subsets were substantially diluted by subset-specific genetic or nongenetic controls. An analysis of a separate population of UM-HET3 mice has provided independent support for the conclusion that genes on chromosomes 4 and 13 exert effects on age-sensitive T-cell subset patterns (17) .
T-cell activation defects
The data presented above show that age-related shifts in T-cell subsets are intimately associated with lifespan and disease risk and that they are under the control of genes that are polymorphic within the commonly used stocks of laboratory mouse, but they provide no insight into the alterations in cell biology that might contribute to diminished immune responses in old age. We have addressed the latter problem by studies of T-cell signal transduction. An earlier review (19) Defects precede TCR-antigen recognition A turning point in these studies was the observation that T cells from young and aged mice had equal amounts of z-associated protein of 70 kDa (Zap-70) enzyme activity, tested in lysates, in the first few minutes after exposure to an activating signal (23); tyrosine-specific phosphorylation of the Zap-70 molecule was equivalent in activated CD4
þ T cells of both young and old mice. This lack of age effect was surprising in view of the clear evidence for age-dependent differences in most downstream-signal events, including phosphorylation of the Zap-70 substrate linker of activated T cells (LAT) in intact T cells (24) . The paradox was resolved by microscopic analysis, using confocal immune fluorescence methods, of conjugates between T cells and hybridoma cells presenting anti-CD3 antibody as a polyclonal activator. CD4 þ T cells from young mice were able to form immunological synapses containing LAT, Vav, protein kinase C y (PKCy), and other components of the T-cell signal complex in about half of the conjugates formed with anti-CD3 hybridoma cells as polyclonal antigen-presenting cells (APCs) (24, 25) , but only 25% of CD4 þ T cells from aged donors were able to generate immunological synapses. A similar discrepancy was noted in a system in which the T cells expressed a TCR specific for a peptide antigen derived from pigeon cytochrome C, using peptide-bearing lymphoma cells as APCs (26) . Synapse formation was an 'all-or-none' reaction, in the sense that those T cells from mice of any age that moved LAT into the synaptic region almost always also moved PKCy as well and vice versa, and then proceeded to translocate the DNA-binding factor, nuclear factor of activated T cells into their nucleus as well (24) . The ability to form synapses was strongly associated with subsequent steps in T-cell activation, in that those CD4 þ T cells which failed to form synapses were predominantly members of a T-cell subset detectable by expression of the multiple-drug resistance pump P-glycoprotein, of which previous work had shown was functionally anergic (5-7). Thus, these results supported a model in which poor signal transduction in CD4 þ T cells from aged mice was the result of an accumulation of cells that were unable to form functional synapses necessary for kinase-mediated activation of downstream stages of the activation process.
Defects in cytoskeletal activation Where, then, lay the key defect(s) in the synapse formation process? New information came from the observation that the defect in T cells from aged donors preceded recognition of antigenic peptides by the TCR. The protocol made use of a system in which naïve CD4 þ T cells from TCR-Tg mice were allowed to form conjugates with lymphoma APCs bearing either agonist peptide (derived from pigeon cytochrome C sequence) or an antagonist peptide that differed from the agonist at a single amino acid. Others had shown previously that antagonist peptides induced a presynaptic response characterized by movement of the cytoskeletal protein talin, but that formation of a fully functional synapse with LAT, Vav, actin, and other components in addition to talin depended on recognition of the agonist peptide sequence (27) . Evaluation of talin rearrangements in the TCR-Tg system then showed that while about 60% of CD4 cells from young mice were able to relocate talin to the APC contact zone in response to agonist or antagonist peptide, the proportion of responsive cells from aged mice was much lower, i.e. about 15% in response to antagonist peptide and at most 31% in responses to agonist (28) . Fig. 4 shows summary statistics from a series of three experiments using six young and three aged donors (28 to the synapse in response to antagonist peptide shows that at least one age-sensitive step in the activation process involves a step prior to the discrimination, by the TCR, between agonist and antagonist peptides. This age-sensitive defect in talin relocation focused attention on other aspects of cytoskeletal remodeling in the T-cell activation cascade. An assay in which CD4 þ T cells from young or old mice were allowed to attach to glass slides showed that slides coated with anti-CD3 (but not with anti-DNP or anti-CD28 antibodies) stimulated many T cells to form pseudopodia and spread out onto the glass surface. Such interactions involve reorganization of the cytoskeleton and polymerization of actin into a ring at the edge of the spreading cell, but do not involve construction of a complete immunological synapse. The data in Fig. 5 , excerpted from a more comprehensive set of experiments using a range of doses and time points (28) , illustrate that CD4 þ T cells from aged mice are less likely than those from young mice to spread out after attachment to anti-CD3-coated slides, whether the cells are derived from CB6F1 mice or (right panel, Fig. 5 ) from TCR-Tg mice in which most of the CD4 þ T cells remain in the naïve subset throughout life.
A third line of analysis involved detection of translocation of CD3z chains from the soluble to the cytoskeletal compartment after stimulation of T cells by cross-linking CD3 to CD4 and CD28. Stimulation of CD4 cells from young mice induced a rapid (5 min) increase in the amount of CD3z associated with the cytoskeletal fraction, with a corresponding decline in CD3z in detergent-soluble form. CD4 þ T cells from aged donors, however, showed neither effect. Fig. 6 illustrates this difference for the p16 form of CD3z, and the original study (28) shows similarly large and significant changes for the p21 and p23 forms of CD3z as well. encounter with TCR-specific stimuli, defects that precede antigen recognition (Fig. 4) , do not require interaction with costimulatory molecules present on APCs (Fig. 5) and modulate interaction of CD3 components with the cytoskeleton (Fig. 6) . These results are consistent with models in which alterations in TCR-cytoskeletal connections contribute to defects in immunological synapse organization and T-cell commitment to cytokine production and blast formation.
Age-dependent changes in CD43 translocation and CD4 glycosylation patterns Activated T cells use cytoskeletal motors not only for assembly of elements of the immunological synapse but also for movement of surface molecules to the distal pole complex (DPC), i.e. to the area of the T-cell membrane opposite from the point of contact with the APC (29) . CD43, a large, heavily glycosylated protein prominently represented at the T-cell surface, is among the molecules that are moved to the DPC after T-cell activation (30) . The large size of the CD43 molecule, along with evidence that CD43 knockout mice are hyperresponsive in some tests of T-cell function (31, 32) , has suggested that removal of CD43 from the area of immunological synapse formation might help to promote functional interaction between the T cell and APC.
To see if age-dependent changes in cytoskeletal function might hinder removal of CD43 from the zone of T cell/APC contact, we used confocal microscopy to count the number of CD4 þ T cells from young or old mice that were able to remove CD43 from the area of T-cell/APC contact using TCR-Tg T cells and peptide-bearing APCs. Fig. 7 shows an image of one such T-cell/APC conjugate in which CD43 (upper left panel) is excluded from the synapse area, identified (upper right panel) by staining for LAT. The proportion of T cells able to exclude CD43 from the synapse decreases dramatically with age (33) (Fig. 7) , consistent with the idea that CD43 molecules might interfere with the T-cell/APC interactions in T cells from aged donors. Analysis of CD43 glycosylation patterns (33) revealed another difference in CD43 properties between T cells from young and aged mice. Although immunoprecipitation data using an antibody specific for cytoplasmic determinants showed no difference in the total amount of CD43 in young and old T cells, flow cytometry showed an increase with age in expression of determinants detected by antibodies (S7 and 1 B 11) specific for the glycosylated forms of CD43. Although nearly all CD4 cells showed some expression of S7 and 1 B 11 determinants, the proportion of cells expressing higher levels of these two molecules increased substantially in the older mice. High-level expression was noted in both naïve and memory T cells (using CD44 levels as an index of memory cell differentiation), suggesting that the acquisition of the heavily glycosylated forms did not require a history of antigen exposure and clonal expansion to memory cells. Interestingly, 80% or more of the CD4 þ T cells with heavily glycosylated CD43 determinants were found to have high levels of surface P-glycoprotein, associated in previous studies with anergy among CD4M cells in both young and old mice (5) (6) (7) . This finding suggested the hypothesis that the accumulation of heavily glycosylated forms of CD43 might contribute to the hyporesponsiveness of the P-glycoprotein-positive subsets of CD4 þ T cells, which become progressively more prominent in aging mice (3).
Enzymatic cleavage of surface glycoproteins restores synapse formation and improves activation of T cells from aged mice The increase with age in CD43 glycosylation together with the decline in the proportion of T cells that can exclude CD43 from the immunological synapse suggested a model in which glycosylated forms of CD43 contribute to the decline in activation of T cells from aged donors. As one test of this idea, we exposed T cells to an enzyme O-sialylglycoprotein endopeptidase (OSGE) that cleaves the protein backbone of molecules, such as CD43 that carry O-linked polysaccharide chains (33) . The results (Fig. 8) showed that brief exposure to OSGE treatment restores the ability of T cells to form synapses when conjugated to peptide-bearing APCs. In cells not exposed to OSGE, positive responses were obtained from approximately 50% to 70% of the young T cells and 16% to 27% of the old T cells; OSGE had little or no effect on the proportion of positive T cells for young CD4 cells, but increased the proportion of responding old cells to a level nearly equivalent to that seen in untreated young cells. Similar results were seen when synapses were scored using antibodies to talin, F-actin, CD3z, or Grb2 (33) . Treatment of the T cells with sialidase from Vibrio cholerae had no effect on synapse formation [not shown in Fig. 8 , refer to Garcia & Miller (33) ], suggesting that the restoration of responsiveness was not due simply to removal of terminal sialic acid residues present on CD43 or other OSGE-sensitive T-cell surface glycoproteins. Furthermore, OSGE treatment of CD4 þ T cells from aged donors restored their ability to translocate talin to the APC contact zone in response to antagonist peptide ( shows levels of CD69 expression in OSGE-treated and control CD4 cells evaluated 6 h after activation by anti-CD3 antibody. CD4 þ T cells from old donors (filled bars) are less responsive than young cells prior to treatment. Sialidase from Vibrio cholerae (VC) does not affect responsiveness of either young or old cells, but OSGE treatment increases the proportion of responding cells in both young and old mice. There is no age difference in levels of responsiveness after OSGE treatment, and both naïve and memory T cells (gated based on expression of CD44) show the effects of OSGE exposure (Fig. 9 , top and middle panels). The figure also depicts CD25 expression measured at 24 h after stimulation; in this case, naïve and memory cells could not be separately evaluated due to the stimulusinduced increase in CD44 levels. It is noteworthy that OSGE improves CD69 and CD25 activation of CD4 cells from young mice, even though it does not increase the proportion of young CD4 þ T cells that can form immunological synapses in APC conjugates (Fig. 8) ; presumably this outcome is a consequence of OSGE-cleavage of surface molecules that would, if intact, interfere with stages in the activation process subsequent to or independent of synapse formation. Fig. 9 also shows that a second sialidase, CP-sialidase, derived from Clostridia perfringens can mimic the effect of OSGE on CD69 and CD25 expression, and Sadighi Akha et al. (34) show that this reagent also increases calcium signal generation in CD4 þ T cells of both young and old mice. This enzyme has similar but not identical substrate specificity with the sialidase from V. cholerae, shown to be ineffective both in the synapse assay (33) and in tests for T-cell activation antigens (Fig. 9) . Both sialidases cleave sugar/sugar bonds; in contrast, OSGE cleaves the peptide backbone of CD43 and other glycoproteins with Olinked glycan groups. More work will be needed to determine to what extent the ability of OSGE and C. perfringens sialidase to facilitate various stages in the T-cell activation cascade depends upon removal or modification of the same (or overlapping sets of) T-cell surface molecules.
T-cell activation: current status and future goals
The evidence reviewed above suggests a working hypothesis for future studies, in which activation defects of T cells from aged mice are attributed at least partly to hyperglycosylation of CD43 and other surface glycoproteins, coupled to or combined with alterations in the cytoskeletal machinery required to remove these bulky molecules from the area of interaction with the APC. The ability of OSGE treatment to restore calcium signals, synapse formation, and induction of surface antigens and cytokine production in CD4 þ T cells of aged mice suggests that OSGE-sensitive molecules interfere with an early step or steps required for a wide range of downstream events in the activation cascade. The mechanism by which OSGE improves function of T cells from aged mice is likely to be considerably more complex than those implied by this simplified model. We have preliminary data, for example, to show that OSGE can promote T-cell activation even when the T cells come from CD43 knockout mice (Berger, Garcia, Sadighi Akha et al., manuscript in preparation) suggesting strongly that OSGE can cleave other O-linked T-cell surface glycoproteins whose destruction facilitates T-cell activation. In addition, we have found that T cells from young and old mice differ substantially in patterns of þ T cells activated after treatment with OSGE or with sialidase (Siase) from Clostridia perfringens (CP). CD69 levels were evaluated 6 h after activation with anti-CD3 antibody and CD25 levels after 24 h. Cells were gated for CD4 expression; for the CD69 study, they were also gated using anti-CD44 for naïve (CD44 low) and memory (CD44 high) subsets. Each bar represents mean and standard errors of the mean for eight young (open bars) and four old mice. Asterisks indicate responses that are significantly different from the values for young CD4 þ T cells not exposed to OSGE or sialidase. 'Control' cultures, shown in the leftmost bars, represent cells in which isotype-matched antibody was substituted for the anti-CD3 antibody during the 6-or 24-h culture. Sialidase from Vibrio cholerae (VC siase) was used as an additional control and does not improve responsiveness (34) .
glycosyltransferase levels and in patterns of binding of lectins specific for different polysaccharide bonds (34) as well as in relative levels of mRNA for specific glycosyltransferases (Berger et al., unpublished data). Thus, much more work will be needed to determine which T-cell surface molecules are differentially glycosylated in specific cell subsets in older mice and to learn which of these alterations leads to functional consequences.
